163 related articles for article (PubMed ID: 7668333)
1. Immunelectronmicroscopic characterization of T4 and T8 lymphocytes and natural killer cells in neuronal ceroid-lipofuscinosis.
Kieseier BC; Goebel HH
Am J Med Genet; 1995 Jun; 57(2):222-4. PubMed ID: 7668333
[TBL] [Abstract][Full Text] [Related]
2. Characterization of T-cell subclasses and NK-cells in lysosomal disorders by immuno-electron microscopy.
Kieseier BC; Goebel HH
Neuropathol Appl Neurobiol; 1994 Dec; 20(6):604-8. PubMed ID: 7898623
[TBL] [Abstract][Full Text] [Related]
3. Topographic variabilities of immunoreactivity to subunit c of mitochondrial ATP synthase and lectin binding in late infantile neuronal ceroid-lipofuscinosis.
Kida E; Wisniewski KE; Connell F
Am J Med Genet; 1995 Jun; 57(2):182-6. PubMed ID: 7668327
[TBL] [Abstract][Full Text] [Related]
4. [Ceroid-lipofuscinosis: ultrastructural study of 8 cases].
Matias C; Cabral A; Tasso T; Portela R; Jorge A; Nunes JF; Soares J
Acta Med Port; 1989; 2(4-5):207-14. PubMed ID: 2618809
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte inclusions in Finnish-variant late infantile neuronal ceroid lipofuscinosis (CLN5).
Rapola J; Lake BD
Neuropediatrics; 2000 Feb; 31(1):33-4. PubMed ID: 10774993
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial damage results in a reversible increase in lysosomal storage material in lymphoblasts from patients with juvenile neuronal ceroid-lipofuscinosis (Batten Disease).
Boriack RL; Cortinas E; Bennett MJ
Am J Med Genet; 1995 Jun; 57(2):301-3. PubMed ID: 7668350
[TBL] [Abstract][Full Text] [Related]
7. Progress in neuropathology of the neuronal ceroid lipofuscinoses.
Goebel HH; Schochet SS; Jaynes M; Brück W; Kohlschütter A; Hentati F
Mol Genet Metab; 1999 Apr; 66(4):367-72. PubMed ID: 10191130
[TBL] [Abstract][Full Text] [Related]
8. Decreased lysosomal subunit c-degrading activity in fibroblasts from patients with late infantile neuronal ceroid lipofuscinosis.
Ezaki J; Wolfe LS; Kominami E
Neuropediatrics; 1997 Feb; 28(1):53-5. PubMed ID: 9151323
[TBL] [Abstract][Full Text] [Related]
9. Sanfilippo disease, type A with some features of ceroid lipofuscinosis.
Wisniewski K; Rudelli R; Laure-Kamionowska M; Sklower S; Houck GE; Kieras F; Ramos P; Wisniewski HM; Braak H
Neuropediatrics; 1985 May; 16(2):98-105. PubMed ID: 3925366
[TBL] [Abstract][Full Text] [Related]
10. Atypical late infantile and juvenile forms of neuronal ceroid lipofuscinosis and their diagnostic difficulties.
Wiśniewski KE; Zhong N; Kida E; Kaczmarski W; Kaczmarski A; Connell F; Brooks SS; Brown WT
Folia Neuropathol; 1997; 35(2):73-9. PubMed ID: 9377079
[TBL] [Abstract][Full Text] [Related]
11. Fingerprint inclusions in non-vacuolated lymphocytes in juvenile neuronal ceroid-lipofuscinosis.
Goebel HH
Clin Neuropathol; 1985; 4(5):210-3. PubMed ID: 2998665
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of subunit c of mitochondrial ATP synthase in urine as a diagnostic screening method for neuronal ceroid-lipofuscinoses.
Wisniewski KE; Kaczmarski W; Golabek AA; Kida E
Am J Med Genet; 1995 Jun; 57(2):246-9. PubMed ID: 7668339
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of neuronal ceroid lipofuscinosis (Batten disease) by electron microscopy in peripheral blood specimens.
Anderson GW; Smith VV; Brooke I; Malone M; Sebire NJ
Ultrastruct Pathol; 2006; 30(5):373-8. PubMed ID: 17090516
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation in Batten disease (neuronal ceroid-lipofuscinosis). Will it work? Preliminary studies on coculture experiments and on bone marrow transplant in late infantile Batten disease.
Lake BD; Henderson DC; Oakhill A; Vellodi A
Am J Med Genet; 1995 Jun; 57(2):369-73. PubMed ID: 7668365
[TBL] [Abstract][Full Text] [Related]
15. Neuronal ceroid lipofuscinoses: pathological features of bioptic specimens from 28 patients.
Simonati A; Rizzuto N
Neurol Sci; 2000; 21(3 Suppl):S63-70. PubMed ID: 11073230
[TBL] [Abstract][Full Text] [Related]
16. [A clinicopathological study of neuronal ceroid lipofuscinosis].
Xiao B
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):278-80, 316. PubMed ID: 1291248
[TBL] [Abstract][Full Text] [Related]
17. Classification of the neuronal ceroid-lipofuscinoses: expansion of the atypical forms.
Dyken P; Wisniewski K
Am J Med Genet; 1995 Jun; 57(2):150-4. PubMed ID: 7668320
[TBL] [Abstract][Full Text] [Related]
18. The dystrophic retina in multisystem disorders: the electroretinogram in neuronal ceroid lipofuscinoses.
Weleber RG
Eye (Lond); 1998; 12 ( Pt 3b)():580-90. PubMed ID: 9775220
[TBL] [Abstract][Full Text] [Related]
19. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs.
Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A
Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
Bernardini F; Warburton MJ
Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
